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1. Introduction 
The evaluation of protein stability in digestive tract is an important topic in various fields of 
biomedical sciences. The most straightforward task within it is the evaluation of food 
quality, as during the food processing the digestibility of a protein could fall dramatically. 
Another task, tightly connected with the previous one, is the evaluation of protein 
allergenicity. This parameter is shown to be dependent on protein’s digestibility, the less 
digestible ones having the highest probability to induce immune response.  Finally, the task 
of development of new peptide drugs also requires digestive stability check for per os drug 
forms that are the most convenient for a patient. 
Current knowledge on protein digestion suggests it to be a multistage process, starting from 
pepsin cleavage in stomach and proceeding through trypsin and chymotrypsin digestion in 
intestinal lumen, and finally involving cleavage by intestinal surface and intracellular 
proteases. The latter two protease groups accomplish the most deep protein degradation. 
An intriguing point is that in spite of this knowledge the models, which include all stages of 
protein digestion, are used primarily in food quality control.  
Protein digestion, specific enzymes, involved in this process, as well as research area specific 
methodology for protein digestibility evaluation is regularly reviewed. However, as a 
common rule, the authors of latter group of reviews ignore the existence of methods with 
similar goals in other research areas, as well as the question of a degree to which any given 
method represents a living organism. The aim of this review is to describe existing models 
for evaluation of protein digestibility with a special emphasis on biological relevance 
provided by distinct model as well as on productivity of each methodology. 
2. Protein and peptide digestion 
Before a discussion of protein digestibility evaluation methods, it seems worthwhile to 
introduce a reader to the current understanding of protein and peptide digestion process in 
order to provide him with a holistic picture of what could happen to an ingested protein. 
That is why this section will give a short description of digestive tract and an evaluation of 
enzymes involved in protein digestion in stomach and intestine. A special emphasis will be 
laid on characterization of intestinal wall peptidases (surface as well as intracellular) with 
description of their specificities and their role in overall protein digestion. 
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2.1 An overview of the protein digestion in the digestive tract 
First of all, is should be noted, that excellent reviews and textbooks are readily available on 
the topic of digestive tract physiology and biochemistry (Freeman & Kim 1978; Widmaier et 
al. 2011), and we refer a curious reader them for more details; here only a short overview of 
this process is presented. 
The digestive tract consists of several interconnected compartments: mouth (grinding and 
moisturizing of food), esophagus (connection and separation), stomach, small intestine 
(food digestion and absorption), and large intestine (food remnants digestion by symbiotic 
microbiota and undigested material excretion). Protein digestion is initiated in lumen of 
stomach, then proceeds in the intestinal lumen and is finalized at the surface and in the 
cytoplasm of intestinal mucosa cells. Additional digestion events occur in large intestine, 
where symbiotic microorganisms either digest protein remnants to amino acids, or convert 
them to other compounds of nutritional value. 
Stomach is the first compartment, which is chemically active towards proteins. Its acidic pH 
serves three major functions: it sterilizes the ingested material, denaturates food protein and 
activates local proteolytic enzymes. Only one protease, pepsin, is secreted in stomach. 
Pepsin does not destruct proteins to amino acids, rather it splits them to smaller parts to 
increase its accessibility for successive digestion steps (Widmaier et al. 2011). 
The core function of stomach is the control of graduated food delivery into small intestine, 
and so it is rather dispensable for the overall protein assimilation. The experimental data on 
animals and patients with total gastrectomy show that the organism even under this 
condition retains the ability to assimilate dietary protein adequately and remains in positive 
nitrogen balance (Freeman & Kim 1978).  
The next digestion phase, pancreatic, occurs in small intestine. It is thought to be more 
critical than the gastric phase. Here the pH changes to more basic and several different 
sources of proteases come into play. The most abundant ones: trypsin, chymotrypsin, 
elastase and several carboxypeptidases, are secreted by pancreatic acinar cells in a form of 
precursors, which are activated by proteolytic cleavage (Widmaier et al. 2011). The first 
three enzymes are endopeptidases; they cleave protein or polypeptide substrates at different 
specific peptide linkages within their secondary structures. Carboxypeptidases are 
exopeptidases and act on terminal peptide bonds at the carboxyl terminus of protein. The 
products of the combined action of the aforementioned enzymes are small peptides and 
amino acids. These small peptides consist of 2-6 amino acid residues and account for over 
60% of luminal amino nitrogen; the remaining 40% is associated with amino acids (Freeman 
& Kim 1978). 
The results of Savoie et al. indicate that the amount and size of the resultant peptides and 
their stability and resistance to exhaustive hydrolysis is strongly influenced by the nature of 
the source protein. For example, while casein and gluten have the highest proportion of the 
1-10 kDa peptide fraction in the first 2 h of digestion, the peptides from gluten are evidently 
less degraded in the subsequent 4 h. The folding and spatial orientation of the protein chains 
could explain this observation; the high number of Pro and Glu residues is expected to have 
contributed heavily in the low accessibility and efficacy of the hydrolytic action of 
pancreatic enzymes on Pro- and Glu-reach proteins  (Savoie et al. 2005). 
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The core properties of the luminal proteases are summarized in table 1, to give the reader an 
understanding of the processes, which take place at different stages of digestion. It should 
be noted that most digestive enzymes are present not as a single entity, but rather as a group 
of slightly different molecules with quite similar substrate specificity and kinetic properties. 
Some authors suggest it to be a sign of evolutionary importance of these enzymes (Silk et al. 
1976). A detailed discussion of these enzymes is, however, beyond the scope of this chapter, 
and we refer a curious reader to the excellent reviews available (Freeman & Kim 1978; 
Turner 1968; Whitcomb & Lowe 2007). 
Besides the common luminal enzymes, which are secreted by specialized organ – pancreas, 
a significant amount of intestinal wall proteases is also present in the lumen. The sources of 
these enzymes are desquamated mucosal cells resulting from active replacement of the 
lining epithelium. An approximate quantity of these enzymes is about 30 g per day 
(Freeman & Kim 1978; Gropper et al. 2009). 
Chemical assay data, thermostability studies, and examination of electrophoretic mobilities 
of luminal peptide hydrolases indicate that aforementioned jejunal enzymes originate 
predominantly from the cytoplasm of intestinal mucosal cells, whereas the brush border of 
mucosal cells is a major source of the enzymes in the ileum. All of these enzymes recognize 
primarily short peptides and are aminopeptidases; they are discussed in more detail in the 
next section. 
The products of luminal proteolysis are free amino acids and small peptides having a chain 
length of two to six amino acid residues. Analysis of post-prandial intestinal contents 
aspirated from human jejunum reveals that approximately only one-third of the total amino 
acid content exists in the free form (Silk et al. 1985). Some of the short peptides are directly 
absorbed by specific transport systems. However, to increase the overall efficiency of the 
assimilation process the mucosal cells of intestinal wall provide an additional source of 
proteolytic enzymes. As these cells line the intestinal wall and are intensively shed into 
lumen, they contribute both to luminal and parietal digestion. A profound characteristic of 
mucosal cells is high aminopeptidase activity. This peptidase activity is located in two main 
subcellular fractions: the cytoplasm and the brush border membrane. The brush border 
membrane fraction is associated with less than 10% of the total hydrolytic cellular activity 
for dipeptides but as much as 60% for tripeptides (Freeman & Kim 1978; Sterchi & Woodley 
1980a). 
The whole digestion process is quite rapid in man, as well as in rat. So, according to the data 
of Curtis et al., 44.9 % of the meal had left the stomach of a rat in 30 min, and 84.7 % of the 
meal had left the stomach in 60 min. At 30 min and thereafter, negligible amounts of 14C-
labeled protein, which was included in the meal, were detected in intestinal contents of 
proximal third of small intestine. At 30 min and 1 hr, 14C accumulated in medial and distal 
thirds of small intestine. At 2, 3 and 4 hr small quantities of 14C were detected in intestinal 
contents of distal third of small intestine and the colon. The absorption of ingested protein 
was virtually complete 2 hr after administration of the meal (Curtis et al. 1978). In human, 
the situation is quite the same: digestion and absorption of dietary protein are completed in 
the jejunum, the whole process of digestion and absorption reaches its maximum at about 45 
min or possibly earlier, and absorption may be largely complete within 75 to 90 min. 
However, the data of some studies show that the remnants of dietary protein can be 
recovered from the ileum as late as 4 hr after a meal (Adibi 1976). Nevertheless, it appears  
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Enzymes 
Compartment 
and localization 
Properties References 
Stomach proteases 
Pepsins: Pepsin, pepsin B, 
gastricsin, chymosin A, renin
Stomach lumen Endopeptidase, 
cleaves at Phe, Tyr, 
Leu, and Val 
(Freeman & Kim 
1978; Szecsi 1992; 
Turner 1968; 
Whitecross et al. 
1973) 
Pancreatic proteases 
Trypsins: Cationic trypsin, 
anionic trypsin, mesotrypsin, 
pancreasin 
Ileum lumen Endopeptidase; 
cleaves peptide bond 
at Lys and Arg 
(Feinstein et al. 
1974; Freeman & 
Kim 1978; Savoie et 
al. 2005; Whitcomb 
& Lowe 2007) 
Chimotrypsins: Two 
isoforms + chymotrypsin-
like protease 
Ileum lumen Endopeptidase, 
cleaves bonds at 
aliphatic amino acid 
residues 
(Bender & 
Killheffer 1973; 
Savoie et al. 2005; 
Whitcomb & Lowe 
2007) 
Elastases: Two isoforms Ileum lumen Endopeptidase, 
cleaves at Ala, Gly, Ser
(Whitcomb & 
Lowe 2007) 
Carboxypeptidases A: A1, 
A2, A3 
Ileum lumen Exopeptidase, cleaves 
aromatic amino acids 
from carboxyl 
terminus of substrate 
(Whitcomb & 
Lowe 2007) 
Carboxypeptidases B: B1, B2, 
N, M, E, AEBP1 
Ileum lumen Exopeptidase, cleaves 
Arg or Lys from C-
terminus of substrate 
(Whitcomb & 
Lowe 2007) 
Intestinal wall proteases 
Brush border 
aminopeptidases (distinct 
enzymes): aminopeptidase 1, 
aminopeptidase 2, 
dipeptidylpeptidase IV, 
gamma-
glutamyltranspeptidase, 
aminopeptidase A, 
aminopeptidase M 
Small intestine 
epithelium brush 
border 
Hydrolyze amino acid 
residue at the N-
terminus  of hexa- to 
tripeptides 
(Kim et al. 1972; 
Sterchi & Woodley 
1980b) 
Cytoplasmic 
aminopeptidases: four 
distinct enzymes 
Small intestine 
epithelium 
cytoplasm 
Hydrolyze amino acid 
residue at the N-
terminus  of tri- and 
dipeptides 
(Kim et al. 1972; 
Schiller et al. 1977) 
Table 1. Principal properties of protein hydrolases 
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reasonable to assume that under normal conditions the greatest portion of dietary proteins 
is digested and absorbed in the upper small intestine (Adibi 1976; Silk 1980; Silk et al. 1985). 
2.2 Enzymes of the intestinal wall 
In addition to the luminal proteases, the mucosal cells that line the intestinal wall also 
possess two kinds of proteolytic enzymes: membrane-bound, which are primarily localized 
in the brush border area, and cytoplasmic. The core difference of these enzymes from the 
luminal ones is that they are oligopeptidases, that is, recognize only short peptides of 2-6 
amino acids in length. The profound characteristics of these enzymes are that they are 
aminopeptidases, so the N-terminal amino acid residue of peptides is the determinant of 
their rate and substrate specificity, and all have pH optima in alkaline (7.5-8.5) range (Adibi 
1976).  
To date, in brush border membranes in human and rat were identified at least 6 
aminopeptidases (aminopeptidase 1, aminopeptidase 2, dipeptidylpeptidase IV, gamma-
glutamyltranspeptidase, aminopeptidase A and aminopeptidase M) (Kim et al. 1972; Sterchi 
& Woodley 1980b), and in the cytosol of the mucosal epithelial cells at least 4 enzymes were 
detected (Kim et al. 1972; Schiller et al. 1977). The specificity towards peptide length is 
distributed unequally between the subcellular fractions:  the majority of dipetides (80 to 
95%) are hydrolyzed by cytoplasmic enzymes (Adibi 1976; Krzysik & Adibi 1977), 10-60% of 
the tripeptidase activity is also in the brush border membrane (Sterchi & Woodley 1980a), 
and activity against tetrapeptides is located exclusively in the brush border membrane 
(Sterchi & Woodley 1980a). The ability of brush border enzymes to hydrolyze penta- and 
hexapeptides has been reported (Adibi 1976), however, little details are still known about 
this activity. 
Some, but not all, cytosolic and brush border membrane peptidases also display some 
preference to the amino acid composition of substrate. Thus, aminopeptidase 1 from brush 
border is most active towards aliphatic tripeptides (Sterchi & Woodley 1980b), although 
most activity against aliphatic peptides is located in cytosol; dipeptidases of brush border 
prefer substrates with aromatic amino acid at the N-terminus (Sterchi & Woodley 1980a). An 
interesting exception are proline-containing peptides, which are hydrolyzed by a special 
hydrolase in the cytosolic fraction (Freeman & Kim 1978; Smith & Bergmann 1944). In 
normal conditions, 80-90% of hydrolase activity in rat and human is localized within the 
cytosolic fraction (Kim et al. 1972), starvation increases the peptide hydrolase activity of the 
cytosol fraction, while that of the brush border fraction is decreased (Adibi 1976).  
The distribution of peptide hydrolase activity between brush border membrane and cytosol 
varies considerably with species (Sterchi & Woodley 1980a), the enzymes from different 
species have different electrophoretic mobility, but, at the same time, by the activity and 
substrate preference they often could be grouped in a strikingly similar manner (Kim et al. 
1972). 
2.3 Peptide and protein transport across the intestinal wall  
The absorption is the last and the most controversial phase of protein digestion. 
Theoretically, an organism requires only amino acids to produce energy and rebuild lost 
proteins. The foreign proteins and peptides should be avoided, as they could transmit 
www.intechopen.com
 
New Advances in the Basic and Clinical Gastroenterology 
 
216 
unwanted signals or even be toxic or mutagenic. The reality, however, is much more 
complicated. Although amino nitrogen in postprandial blood is almost entirely in the form 
of free amino acids, few small peptides do appear in portal blood. These include short 
proline- and hydroxyproline-containing peptides after gelatin ingestion, and both carnosine 
and anserine after ingestion of certain meats, specifically chicken breast. Significant amounts 
of whole protein and other large macromolecules are absorbed intact by fetal and neonatal 
small intestine (Freeman & Kim 1978). 
The transport of amino acids is active and depends on a gradient of sodium ions across the 
brush border membrane of intestinal epithelial cell. Three major group-specific active 
transport systems exist for: a) monoamino monocarboxylic (neutral) amino acids, b) dibasic 
amino acids and cysteine, and c) dicarboxylic (acidic) amino acids (Silk et al. 1985). 
Methionine and the branched chain amino acids (leucine, isoleucine, and valine) are 
absorbed most rapidly from amino acid mixture. Among the 18 common dietary amino 
acids, aspartate and glutamate are most slowly absorbed, as are tryptophan and threonine 
among the eight essential amino acids. As a group, essential amino acids are better absorbed 
than nonessential amino acids (Adibi 1976). 
Small peptides are also actively absorbed, but their transporters are different from those for 
amino acids. As such, dipeptides and tripeptides are actively transported against a 
concentration gradient, and they share a common transport mechanism. There are at least 
two general strategies for transport of small peptides. First, small peptides resistant to brush 
border membrane peptidases appear to be transported intact across the brush border 
membrane and are later hydrolyzed by the cytoplasmic peptidases. Second, small peptides, 
having a higher affinity for brush border membrane peptidases are likely hydrolyzed 
primarily at the brush border membrane. The hydrolysis products, including free amino 
acids and dipeptides or tripeptides, are then absorbed by their respective transport systems 
(Freeman & Kim 1978; Sterchi & Woodley 1980a). There are little data on the active transport 
of tetrapeptides, and these data do not support the hypothesis on existence of such process 
(Silk et al. 1985). 
One of important differences between amino acid and small peptide transport is that the 
capacity of free amino acid absorption is far greater in the jejunum than in the ileum, while 
that for peptide transport is evenly distributed. High-affinity amino acids competitively 
inhibit the absorption of low-affinity amino acids. However, absorption rates of amino acids 
by the intestinal epithelial cells are significantly greater in the form of low molecular weight 
peptides than the corresponding free amino acids, with the competition between amino 
acids being abolished. These spatio-temporal events directly influence amino acid 
concentration in blood flow, which in turn affects many physiological and metabolic 
phenomena as well as influencing the overall rate of protein synthesis (Savoie et al. 2005). 
As to the peptide and protein molecules that are larger than 6 amino acids, so they pass 
through the intestinal wall differently. There are several routes, which allow the more or less 
non-specific passage of molecules: specialized microfold cells of Peyer’s patches, isolated 
lymphoid follicles, through the epithelial cells (transcellular pathway) and between these 
cells (paracellular pathway) (Perrier & Corthésy 2011). The mucosa-associated lymphoid 
tissue, comprising Peyer’s patches and isolated lymphoid follicles, is covered by the follicle-
associated epithelium containing microfold cells. These cells have the capacity to engulf 
particulate antigens, and transport them to underlying dendritic cells thus contribute 
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towards possible immune response. Paracellular transport across the epithelial barrier is 
highly regulated and is able to leave access to small molecules (44 angstroms), but also 
allows the passage of larger molecules including small peptides and bacterial 
lipopolysaccharides (500-1500 Da). A particular subset of dendritic cells (CX3CR11) is 
known to extend their dendrites in the lumen to collect bacteria under steady-state 
conditions, a process further accentuated upon inflammation. It is not yet clear whether this 
process can also take place for food antigens and whether this could contribute to the 
selective passage of antigens across the intestinal barrier and further presentation to the 
mucosal immune system (Perrier & Corthésy 2011). 
Normally, large molecules are restricted from access to the intestinal wall by the mucus 
layer, which blocks passage of molecules of over 17 kDa (Jin et al. 2006). The intestinal cell 
layer permeability towards peptides and large molecules, on the other hand, is tightly 
bound to the external conditions. Thus, during fasting the efficiency of small peptide 
absorption increases (Silk et al. 1985). Then, a specific consequence of allergic reactions is the 
increased permeability towards large molecules via paracellular pathway, which can persist 
for a significant time after acute immune response is over (Perrier & Corthésy 2011). In vitro 
studies on confluent cultures of the enterocyte-like cell line Caco-2 have shown, that a model 
protein beta-lactoglobulin is taken by endocytosis, and whilst the majority of the protein 
was degraded intracellularly, around a third was transported across the cells (Wickham et 
al. 2009). 
2.4 Comparison of relative roles of protein digestion stages 
The functional importance of different stages of protein digestion process is unequal, albeit 
the exact significance of each of them varies depending on whether food 
toxicity/allergenicity or nutritive value is considered. As one could expect, the nutritive 
value of a protein is the most stable characteristic in context of the involvement of different 
digestive tract compartments. Thus, stomach and mucosal peptidases are dispensable for 
this function, and individual amino acid transport is also not very important if peptide 
transport is alive. The core functionality appears to be the one of pancreatic endopeptidases, 
which should split food protein into peptides of 3-2 amino acids; this activity is logically 
protected by the existence of multiple enzyme isoforms. 
In addition to this, it should be noted, that peptide transport role is more impotant than the 
amino acid one. In evaluations involving both highly digestible proteins such as egg and 
less digestible protein sources such as corn as well as free amino acid mixtures, the food 
source of protein routinely gave better nitrogen balance test results than did the counterpart 
amino acid diets. Explanations for these results included the following: (a) that the 
immediate availability of purified amino acids might lead to overall overtaxing of 
absorption mechanism systems or competition among particular amino acids might lead to 
selected competitive inhibition of absorption of particular amino acids and hence to reduced 
efficiency of their utilization; (b) that rapid absorption of amino acids over a short period of 
time rather than over a longer period of time might overtax the body’s ability to efficiently 
use amino acids for protein synthesis purposes, thus leading to increased deamination of 
amino acids and utilization for energy purposes; (c) that experimental diets containing 
purified amino acids were not truly matched to those containing food proteins in contents of 
all trace nutrients and results reflected these deficits (Kies 1981). 
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The situation changes significantly, as one tries to evaluate food protein toxicity and 
allergenicity. In this case stomach phase value greatly increases, as the low pH in this 
compartment often provides denaturation and thus inactivation and detoxification of 
ingested proteins. The oligopeptidases of the intestinal mucosa are not very important for 
the toxicity prevention, albeit they play a role as protectors against exogenous signals, as 
many proteins could possess hormonal properties (Widmaier et al. 2011). The pancreatic 
enzymes are still important for the defensive function, as they split large proteins into small 
chunks, thus destroying potential immunological epitopes. 
3. The evaluation of protein and peptide digestibility 
There are several approaches to the evaluation of protein digestibility. The most common of 
these include single-enzyme systems, based on pepsin and/or trypsin; whole-organ 
systems; cannula incision; and immobilized multiple digestive enzymes system. The latter 
model provides the most relevant data, while pepsin hydrolysis is the simplest. Several 
more rare models will be also described (for example, the use of cell fractions of small 
intestine, culture of Caco-2 cells, yeast surface enzymes, tissue fragments). 
3.1 Isolated enzymes 
One of the simplest models of protein digestion is the use of the purified major enzymes of 
stomach (pepsin) and pancreas (trypsin and chymotrypsin)  (Horii et al. 2009; Huang et al. 
2010; Kamata et al. 1982; Nielsen et al. 1988; Stanic et al. 2010; Yagami et al. 2000), 
implemented either separately of subsequently. The products of the digestion are usually 
analyzed using SDS-PAGE with the separation range from 3 to 20-30 kDa (Stanic et al. 2010; 
Yu et al. 2011) or reverse-phase HPLC (Bublin et al. 2008). In rare cases, mass spectrometry 
is also employed to characterize the digestion products (Dupont et al. 2010). 
The procedure of pepsin and trypsin/chymotrypsin digestion is defined in the US and EU 
Pharmacopoeias (Council of Europe 2004; United States Pharmacopeial Convention 2006), 
and prescribes the exact composition of the incubation medium, enzyme to protein ratio and 
incubation time. 
Several optimizations of enzyme digestion assay exist. First of all, the inclusion of non-protein 
components of gastric and intestinal juice, such as phosphatidyl choline and bile, and some 
potential food components (pectin) could significantly change the analysis result (Bublin et al. 
2008; Dupont et al. 2010; Mandalari et al. 2009; Polovic et al. 2010). Not all proteins respond to 
such changes, but sometimes partially unfolded form of the protein is able to penetrate into the 
phosphatidyl choline vesicles. These interactions are probably responsible for slowing of 
gastric digestion by reducing the accessibility of the protein to pepsin (Moreno et al. 2005). 
Another option is the use not only of the major luminal proteases, but also of other enzymes: 
aminopeptidase M, leucine aminopeptidase, carboxypeptidase A and carboxypeptidase Y 
(Dizdaroglu et al. 1984; Tonglet et al. 2001), or modeling of the subsequent interaction of food 
protein with saliva, gastric juice and duodenal juice (Versantvoort et al. 2005), and heating 
during food processing (Nielsen et al. 1988), a group of approaches which should be 
definitively considered if some protein seems to be stable. Horii et al. implemented another 
interesting modification of enzyme digestion procedure. They introduced test protein into the 
incubation medium not as a solution of individual molecules, but as a component, expressed 
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on the surface of a whole yeast cell. The aim of this study was to check the stability of 
expressed oral vaccine, and it has shown that indeed, a protein displayed on the yeast cell 
surface had an increased resistance to pepsin, possibly due to pepsin underwent steric 
hindrance and only digested the outermost side of the yeast cell wall protein (Horii et al. 2009). 
An unquestionable advantage of individual enzyme digestion method is its simplicity and 
speed, as the whole analysis takes only about 2 to 3 hours to complete (including the 
products separation) and does not require any specific instrumentation or animal 
procedures. Wickham et al., however, notices, that such models «are particularly useful 
where there is limited digestion, e.g. stomach, but are less applicable for total digestion 
studies. These types of models are predominately used for digestion studies on simple foods 
and isolated or purified nutrients, and are therefore ideal for assessments of the digestibility 
of isolated allergenic proteins» (Wickham et al. 2009). 
3.2 Isolated digestive tract compartments 
An intermediate between in vivo and in vitro protein digestibility assays is the utilization of 
isolated digestive tract compartments (Polovic et al. 2010; Wickham et al. 2009). The 
experimental procedure requires an animal to be sacrificed immediately before the 
measurement. After that, the required compartment is surgically removed and either placed 
into a vial with a simulated fluid of this compartment, or sealed both sides with the salt 
mixture with substrate within. A variation of this technique implies the inversion of a 
digestive tract compartment inside out before sealing, so the resultant bag is put into a 
beaker with the substrate-containing solution, and the digestion products diffuse to the 
internal volume of such bag. Some researchers add glucose to the incubation medium to 
provide the tissue with energy. 
The strong point of this approach is that the digestion and absorption systems of the 
intestine remain intact, and so the biological significance of the obtained results is very high, 
and the question on whether the digestion products really pass through the intestinal wall is 
immediately answered. The isolation of reaction products is also rather simple, as they are 
automatically separated from the source protein and mucosal proteins (if a sealed 
compartment bag is employed). The downsides of this method are, of course, high animal 
requirements and low suitability for high-throughput screening. 
3.3 In vivo methods 
In vivo methods, albeit the most complex ones, are at the same time the most informative 
ones. The two possible strategies within this group are based on the evaluation of either the 
remnants of the substrate within or at the end of digestive tract, or of the assimilation of the 
digestion products by the organism. 
The methods based on protein nitrogen utilization by an organism are subject of several 
great reviews, and we refer a curious reader to them for more details (Bender 1958; Darragh 
& Hodgkinson 2000; von der Decken 1983). Below, a short description of method families 
will be given. 
The first group of methods (protein efficiency ratio, net protein retention, rat-repletion 
method) use direct determination of the weight of animals, fed with a test protein. The 
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variations of this method lie in the employment of non-protein diet fed rats as a control 
group or starvation of animals before the introduction of a test meal  (Bender 1958; Henry 
1965). A variation of these methods suggests the determination not of the animal weight, but 
rather of amount of a specific tissue (liver, muscle, etc.), laid down while feeding on a test 
protein (Bender 1958; Mokady et al. 1969). These include protein retention efficiency and 
liver protein utilization. It should be noted, that the original growth determination methods 
are very animal-sparing, while the more advanced assays usually implicate animal death in 
order for some parameter to be determined. 
Another group of methods, developed with the aim to overcome the not-so-obvious 
relationship between protein in diet and growth rate, introduces direct determination of 
nitrogen either in food before and after passage through digestive tract, or in animal carcass; 
a variant of latter analysis implicates the division of animal group in several parts with 
subsequent determination of carcass nitrogen at different time points (Bender 1958). The 
methods in this group are Thomas-Mitchell method, N-balance index method, carcass-
nitrogen method and growth and nitrogen balance method. In some variations of nitrogen 
retention methods protein isotope labeling is required. 
The further development of nitrogen analysis concept led researchers to the development of 
some biochemical methods for protein nutritive value determination. These methods are based 
on several parameters, which strongly correlate with tissue growth: polyribosomal profiles or 
ribosome activity and content; the activity of enzymes involved in urea metabolism or 
transamination reactions; 3-methylhistidine (an excreted-only myosin component) production 
and creatinine excretion (Bender 1958; von der Decken 1983). Ribosome activity is quite 
informative, as it is sensitive enough to detect small differences in protein quality. The latter 
two parameters, on the other hand, are measured in urine and thus are suitable for humans. 
The current recommendation, when calculating a protein digestibility, is to determine the 
digestibility of a dietary protein across the entire digestive tract, using the rat as a model 
animal for humans. This fecal digestibility value is subsequently corrected for endogenous 
contributions of protein using a metabolic nitrogen value determined by feeding rats a 
protein-free diet, a task for which the protein digestibility-corrected amino acid score 
(PDCAAS) was introduced. To calculate a PDCAAS, the availability of the amino acids in a 
dietary protein is assessed based on the digestibility of total nitrogen (N) in that dietary 
protein. Digestibility is defined as the difference between the amount of N ingested and 
excreted, expressed as a proportion of N ingested. Although accepted as the recommended 
procedure, the use of fecal digestibility coefficients to evaluate amino acid availability is 
thought to be inherently inaccurate due to the metabolism of both dietary and endogenous 
proteins by the hindgut microbial population (Darragh & Hodgkinson 2000; Kies 1981). 
In fact, the aforementioned techniques are not precisely suitable for protein digestibility 
evaluation. The problem is that they measure protein assimilation and do not provide any 
data on how exactly a particular protein was or was not digested and transported. This 
hindrance is circumvented in the second group of in vivo approaches, which include 
swallowed probe utilization, anastomosis and cannula incision (Darragh & Hodgkinson 
2000; Faber et al. 2010). 
Anastomosis involves transecting the ileum anterior to the ileocecal junction and attaching 
this to the descending colon. This allows a quantitative collection of ileal digesta, but many 
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studies have shown that anastomosed animals have an altered physiology compared with 
intact animals. It should be noted that human ileostomates may also have an altered 
physiology compared with intact humans, which could also call into question the validity of 
using human ileostomates for the collecttion of ileal digesta (Darragh & Hodgkinson 2000). 
The insertion of a re-entrant cannula involves transecting the terminal ileum and sealing the 
two ends. A cannula is inserted into each end of the sealed ileum and the two cannulae are 
joined. This allows a quantitative collection of digesta. The surgery to insert a re-entrant 
cannula is complex, however, and involves total transection of the ileum. Blockage of the 
cannula is a common complication. Simple T-piece cannulation and postvalve T-cecum 
cannulation have the distinct advantage of maintaining the ileocecal valve intact and 
avoiding ileal transection; in this case there is also no surgical interference with the small 
intestine. In addition to that, most of the digesta should pass through such cannula during 
sampling, as the ileocecal value protrudes directly into it (Darragh & Hodgkinson 2000). 
The in vivo methods of protein bioaccessibility determination, such as retained nitrogen 
analysis, cannula incision and swallowed probe sampling, undoubtedly provide the most 
relevant data. However, their major drawback is experimental complexity and practical 
impossibility of any reasonable screening. 
3.4 Digestive tract simulators 
Most of the aforementioned models, excluding the animal ones, lack two important 
characteristics of digestive tract — the mechanical forces, exerted by stomach and intestinal 
walls, and the fact that food arrives into stomach and upper intestine not as a solution or an 
emulsion, but rather as a bolus with different accessibility of its internal and external 
contents for the enzymatic machinery. The digestive tract simulators try to overcome this 
situation. Usually they represent complex devices, consisting of several mixing chambers 
with programmatically controlled pH, mixing speed, temperature and valves between them, 
which provide a definite transition time from one compartment to another. The 
compartments that imitate intestine contain immobilized enzymes, either trypsin and 
chymotrypsin, or more complex mixtures including proteases of intestinal wall. The system 
is filled with simulated gastric and intestinal fluid plus phospholipids and/or bile, and the 
test substances are delivered into the system either in form of solution or within agarose 
beads (a way to mimic food bolus). The result of protein digestion in such system could be 
analyzed at any stage; the commonly employed analytical methods are SDS-PAGE (mass 
range 2-15 or 14-60 kDa) and reverse phase HPLC. 
The most representative example of such device is the Dynamic Gastric Model, described by 
Vardakou et al. (Vardakou et al. 2011). It is composed of three parts, the main body 
(fundus), the antrum and the valve assembly. In the main body of the model the 
inhomogeneous mixing of the stomach is reproduced by gentle contractions induced by 
computer-controlled changes in the applied pressure of water in the thermostated water 
bath surrounding the main body. Gastric acid and enzymes are added from a dispenser that 
is floating on the top of the main body contents. The dispenser is designed in such a way as 
to deliver the enzyme and acid evenly from the sides of the main body, replicating the 
human gastric secretions originating from the walls of the stomach. The rate of addition of 
both enzymatic and acid secretions is also computer-controlled. The food material is 
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allowed to move from the main body into the antrum, and vice versa. The artificial antrum 
simulates the strong shear forces of the human antrum to reproduce the breakdown of the 
food particles and the preferential sieving observed in vivo. The mechanical processing of 
the food within the antrum is achieved by the sliding of a piston within a barrel, which 
forces the material through an elastic annulus where selective sieving takes place. Once 
ready, the processed bolus is ejected through the valve assembly and can be collected for 
further analysis. 
Another widely used system is the Immobilized Digestive Enzyme Assay (IDEA), 
developed by Schasteen et al. (Schasteen et al. 2002). This system is somewhat more simple, 
and concentrates not on the grinding forces, but rather on the mixing of the «ingested» 
components and the food transition times through various digestive tract compartments. 
The overall digestion procedure consists of a stepwise acid solubilization, pepsin digestion, 
neutralization, trypsin, chymotrypsin and intestinal peptidase digestion followed by 
analysis of hydrolysis products. As follows from the model name, it relies on the glass 
beads-immobilized enzymes, and this allows for substantial costs reduction. The downside 
of this particular model is very long analysis time — up to 2.5 days. 
The digestive tract simulators possess several advantages. They are more efficient at 
predicting of the fate of tablets within the gastrointestinal tract and more accurate at the 
simulation of the interaction of investigated protein or peptide with other meal and chyme 
components. The use of immobilized enzymes allows the reduction of experiment costs. 
However, the pay-off of these systems lies within their design: the complete analysis 
procedure usually takes a day or even two, and the complexity of the system dramatically 
reduces the throughput, as usually only one protein could be analyzed by one device at 
once. Finally, such machines are usually too complex to build by a research team, and thus 
require a substantial capital investment at the initial stage of a research project. 
3.5 Other approaches 
Beyond aforementioned widely used approaches to study of protein digestibility, several 
less common or hybrid ones also exist. 
First of all, when it comes to the evaluation of protein nutritive value, the simplest way to 
determine it is to calculate relative quantity of essential amino acids in the test protein 
relative to some well-known food protein. Hansen et al. (Hansen 1975) describes two such 
indices: Essential Amino Acid Index (EAAI) and Arnoulds index. The reference protein in 
both cases is egg protein; the latter index differs by including of the sum of the non-
essential amino acids (NEAA) as part of equation. An unquestionable advantage of the 
amino acid scores is very low requirement of experimental work for production of 
preliminary estimates about a protein. However, this method does not take into account 
any properties of a protein, thus making impossible to draw any conclusions on its real 
bioaccessibility. 
Then, von der Decken et al. point out to the fact, that the protozoan Tetrahymena pyriformis W 
has a proteolytic enzyme to digest proteins and similar to human needs for essential amino 
acids, and thus could be a model for protein digestion (von der Decken 1983). Time 
consumption of such model is, however, rather high (48 to 66 hours), and the details of 
animal digestion process are missed as well. 
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Our group has recently suggested an assay, that tries to replicate the conditions of parietal 
digestion in small intestine, at the same time maintaining capability for high-throughput 
sample analysis (Akimov et al. 2010). The active component of this system is a fragment of 
rat stomach or intestinal wall, immersed in simulated gastric or intestinal fluid. The 
products are analyzed by HPLC. The utilization of tissue fragments allows for reduction of 
animal consumption, while still maintaining the whole set of intestinal peptidases and 
providing some phosphatidyl choline in the medium. The assay design is suitable for the 
processing of 40 samples per day. 
To simultaneously determine protein digestibility in small intestine and transport through 
epithelial cells, a hybrid model is often employed (Dhuique-Mayer et al. 2007; Jin et al. 2006; 
Versantvoort et al. 2005). The intestinal epithelium is represented by the Caco-2 cell culture, 
which is grown to the monolayer state on a membrane that separates two chambers. A test 
protein solution with digestive enzyme or after in vitro digestion is applied in one chamber 
and, if transport is possible, the products are collected from the second chamber. Two 
optimizations of this experimental design have been proposed: first, a mucin layer could be 
applied on the surface of the cell culture, thus mimicking the real mucus layer, which exists 
in intestine. Mucin protects cells from damage by luminal digestive enzymes and limits the 
passage of large (over 1500 Da) molecules to the cell surface (Jin et al. 2006). Second, Caco-2 
cells could be co-cultured with HT29-MTX cells, which imitate mucus-producing cells of 
small intestine; this approach could be considered a more natural variant of previous 
modification (Yao et al. 2010). The core complication of such methods is the requirement for 
the facilities for operations with animal cell cultures. On the other hand, the model could be 
used for medium-sized screening, has a decent degree of intestinal wall imitation and thus 
the obtained results are quite relevant. 
The final and most promising approach is the molecular modeling. In a work by Foltz et al. 
(Foltz et al. 2009) a special database was constructed to study the relationship between 
peptide structure and activity, permeability, and digestive stability. For this purpose, a total 
of 228 dipeptides were synthesized and their intestinal stability was evaluated by in vitro 
digestion. Then, a quantitative structure-activity relationship (QSAR) modeling was 
performed using partial least squares regression based on 400 molecular descriptors. The 
correlation coefficient for the best fit model was 0.76, and proteolytic stability for 12 new 
peptides was successfully predicted. As it is seen from the description above, molecular 
modeling has one major drawback: it requires a huge amount of preliminary data to build 
an efficient model. After that, it offers great speed and low experimental costs, but the 
aforementioned initial stage makes this approach suitable only for large screening 
experiments. 
4. Current view of protein stability evaluation in different fields  
The common approaches to the determination of the protein and peptide digestibility in 
different areas of research varies significantly: 
 Allergenicity studies are usually the simplest ones and rely on direct hydrolysis of test 
substrate by pepsin and a combination of trypsin with chymotrypsin in simulated 
gastric and intestinal fluids. 
 Biological value is most commonly determined using animal assays. 
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 The studies on the properties of digestive enzymes rely on the purified enzymes or on 
fractionated homogenates of the parts of gastrointestinal tract. 
 Pharmacological studies tend to use complicated devices for the evaluation of the 
ability of a particular pharmacological form to degrade in specific compartment of 
digestive tract. 
In fact, the stability towards protease degradation is not considered to be a basic method for 
the evaluation of potential protein allergenicity, albeit the resistant proteins are usually 
allergenic  (Fu 2002). To better understand the data on the digestibility of any potential 
immunogenic peptide, a basic picture of the underlying mechanisms is necessary (for more 
details reader is referred to an excellent review by Huby et al. (Huby et al. 2000)).  
Allergic sensitization to proteins involves the induction of IgE type antibodies production of 
sufficient magnitude by differentiated B-lymphocytes to facilitate the elicitation of an 
inflammatory reaction following subsequent exposure to the same (or a cross-reactive) 
allergen.  For a B cell to differentiate into a plasma cell and produce antibodies, the B-cell 
receptor expressed on its surface must bind to specific B epitopes on the surface of the 
protein antigen. The antibodies subsequently produced by the plasma cell, into which the B 
cell differentiates, have the same specificity as the B-cell receptor, and are therefore able to 
bind specifically to the same B epitopes on the surface of the protein antigen. Efficient 
secretion of antibodies normally requires that the B cells receive help from T-helper cells 
that specifically recognize separate epitopes on the same protein antigen. Such recognition is 
mediated by the T-cell antigen receptor, which delivers stimulatory intracellular signals to 
the T cell. Allergenic proteins per se cannot be recognized by T cells; the proteins must first 
be processed and then presented by specialized antigen-presenting cells (APCs) (Gorovits 
2010; Huby et al. 2000). 
After the first contact with an antigen the T-helper-stimulated B-cells differentiate and 
become ready to produce antibodies. Thus, if such antigen is encountered for the second 
time, there will be some antibodies against it present in the blood flow, and the production 
of their large quantities will start immediately. The IgE antibodies, however, serve mainly as 
information transducers during allergic response. After antigen recognition they bind to the 
Fc receptors for IgE (FceR) on the surface of basophils and mast cells; for these cells to 
become activated and secrete histamine and other inflammatory mediators their receptors 
need to dimerize. Thus, the peptide is to be large enough to bind at least two antibodies, 
which will bring two FceR together. The minimal length of peptide chain, which could be 
recognized by IgE antibody (epitope), is 15 amino acids, and thus the minimum size of an 
immunogenic peptide should be around 30 amino acids or 5-6 kDa  (Van Beresteijn et al. 
1994). At the same time, the sensitization stage, when an antigen is recognized by T-cells 
and undifferentiated B-cells, requires only one epitope and thus a peptide size of around 3 
kDa (Moreno 2007; Van Beresteijn et al. 1994). 
The discussion above clearly indicates the valid conditions of digest products analysis: 
HPLC and MALDI are always informative enough, but SDS-PAGE is appropriate only if it 
includes molecular masses of 2-3 kDa, which unfortunately is not always the case (Huang et 
al. 2010; Yagami et al. 2000; Yu et al. 2011). 
Even after all the requirements for the stability assay of a potential allergen are met, the 
results should be interpreted with caution, as some stable proteins are not allergens at all, 
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and some other, which are completely degraded in the experimental conditions, still induce 
immune response in vivo (Faeste et al. 2007; Fu 2002; Jensen-Jarolim & Untersmayr 2006).  
One of the complicated moments during the immune response is that depending on the type 
of T-cell, the type of antibodies produced by the B-cell could be changed: Th2 cells produce 
a cocktail of cytokines that, among other actions, encourage plasma cells to switch to 
synthesis of IgE, while Th1 cells typically produce interleukin 2, interferon gamma, and 
tumor necrosis factor (TNF)-alpha/beta, that together downregulate IgE synthesis. Only one 
type of stimulation could be active for a given antigen, as Th1 cytokines suppress Th2 cell 
development, and vice versa. Structural investigations of several allergens have identified T 
epitopes implicated in the selective development of Th2-type lymphocytes. Some allergens, 
such as ovalbumin, have only a few epitopes that preferentially induce a Th2 response, 
whereas others, such as beta-lactoglobulin, have many. The potential to induce a polarized 
(Th1 or Th2) response is not exclusively an intrinsic property of particular epitopes; the 
quality of the T-cell response to any given epitope depends upon many factors, including 
the dose of protein or peptide given, the affinity of the peptide for MHC class II receptor, 
and the longevity of the class II/peptide complex.  Together, these parameters act to 
influence the dynamic epitope density on the surface of APCs. It is generally agreed that 
parameters that serve to increase ligand density, including greater affinity to MHC class II, 
higher levels of ligand loading, or longer-lived complexes favor Th1-type responses (Huby 
et al. 2000). 
In addition to the possible anti-allergic action of Th1 epitopes, a significant variety into 
experimental results is introduced due to the experimental conditions differences. Several 
investigators term protein as «stable» after incubation times ranging from 8 to 60 min 
(Bannon et al. 2003; Fu 2002; Herman et al. 2006). As far as the unstable proteins usually 
survive less than 15 sec in the similar assay conditions, such conclusion seems to be quite 
correct. However, the 8-min survival could potentially be an indication of the protein 
instability, as the simplified conditions of simulated gastric and intestinal fluid do not take 
into account intestinal mucosa peptidases or minor luminal endopeptidases. Then, albeit 
standardized in the last period, the enzyme to substrate ratios vary between different 
research groups (Herman et al. 2006), and thus obtained stability or instability may not 
adequately reflect the reality. 
Finally, the conditions inside the digestive tract during the potential allergen ingestion are of 
crucial importance. For example, during inflammation the permeability of digestive tract is 
increased (Perrier & Corthésy 2011); then, any elevation of the pH should result in 
hindrance of peptic degradation. Numerous situations with elevated stomach pH are 
known, e.g. in early childhood, in elderly, or in chronic atrophic gastritis. Moreover, there is 
a number of pathologies, like gastritis or ulcer, where acid neutralization or inhibition is an 
important therapeutic goal. Acid neutralization is state of the art during surgical care, 
corticosteroid or analgesic treatment. Moreover, anti-acids, H2-receptor blockers and proton 
pump inhibitors are increasingly consumed without prescriptions due to liberalization of 
the market by over-the-counter sale (Jensen-Jarolim & Untersmayr 2006). 
As a logical consequence of the aforementioned complications, immunogenicity assessment 
is typically done using a multistage strategy, generally including an digestive stability and 
antibody affinity screening assay, a specificity confirmation step, and in some cases a 
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characterization step. Samples are first evaluated in a screening assay, for which an assay 
threshold has been set based on the variability of samples from a drug naïve target patient 
population. Screen positive samples are further evaluated in a confirmatory assay to verify 
whether the signal observed in the screening assay is a result of a specific response to the 
protein therapeutic treatment. Confirmed positive samples are then put into downstream 
methods for sequential characterization based on the comprehensive consideration of 
immunogenicity risk assessment and mechanism of action for the protein therapeutic 
(Gorovits 2010; Peng et al. 2011). 
The studies of protein nutritive value usually rely on the in vivo experiments or on the data 
on protein amino acid composition. The point is that the most important aim of such studies 
is to tell, whether a given protein (perhaps after some processing) is suitable for supplying 
body needs for energy and essential amino acids. The question on how does an organism 
manage to consume that protein is often ignored, albeit it is tempting to speculate that the 
exact metabolic route from the whole protein to the amino acids and energy inside body 
cells could be important as well. One should note that as it was shown in section 2, there are 
several conceptually different steps in protein digestion (denaturation and splicing in large 
chunks in stomach, splicing in tetra- to dipeptides and individual amino acids in small 
intestine and various processing by the large intestine microbiota), whose efficiency could 
be independently affected by the protein structure and modifications, and thus during some 
pathological conditions a protein of a high nutritive value could suddenly lose it. 
The in vivo evaluation of nutritive value consists of animal feeding with test protein with 
subsequent analysis of either the amount of absorbed or unabsorbed protein fractions, or the 
degree to which such meal is able to sustain animal growth. The experiments are usually 
quite long, expensive and involve complex manipulations with animals. The direct 
determination of protein amino acid composition is much simpler. The only complication of 
such approach is that the degree to which the constituent amino acids of a food protein are 
actually available to the body is determined by such factors as protein configuration, amino 
acid bonding, other constituents of the diet, and the physiological condition of the 
gastrointestinal tract of the individual person or animal involved. However, the correlation 
between prediction and performance is quite good: prediction for poor performance of 
proteins devoid or nearly devoid of an essential amino acid as well as of good performance 
for proteins containing all essential amino acids according to idealized patterns is excellent. 
However, fine-line predictions of intermediate quality are less accurate, and surprises are 
not uncommon (Kies 1981). Thus the in vivo models are still a preferred way for nutritive 
value analysis. 
Enzymatic studies are usually concerned not with the stability of a some protein, but rather 
with the distribution, specificity and kinetics of a particular enzyme, and thus they usually 
implement some procedures of purification from animal tissues (Krzysik & Adibi 1977; 
Smith & Bergmann 1944; Sterchi & Woodley 1980a) or of expression of a recombinant 
enzyme in some prokaryotic or eukaryotic cells (Hauri et al. 1985; Lentze 1995). The 
applicability of such procedures is usually quite legitimate, albeit the biological significance 
and theoretical value of the obtained results could vary. The enzyme-to-substrate ratios in 
such studies usually do not resemble the in vivo situation, and thus the real significance of a 
given enzyme for the digestive process could not always be predicted. The differences of 
purification procedures complicate the integration of data from various research groups into  
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Name Reproduced conditions
Time to complete and special 
conditions 
Reference 
In vitro methods 
Simulated gastric 
fluid 
Stomach lumen without 
mechanical forces after 
individual ingestion 
Hours (Thomas et al. 
2004) 
Simulated 
intestinal fluid 
Intestinal lumen without 
shed mucosal cells and 
mechanical forces after 
individual ingestion 
Hours (Tonglet et al. 
2001) 
Amino acid score Ability of protein to  be 
a source of essential 
amino acids 
Hours (Hansen 1975) 
Organ fragments Mucosal and 
intracellular digestion 
Hours; HPLC or MALDI 
analysis 
(Akimov et al. 
2010) 
A device with 
immobilized 
enzymes 
Luminal digestion with 
mechanical forces ant 
transitional times 
without mucosal 
enzymes 
Hours (single compartment) to 
days (whole digestive tract); 
requires a special device 
(Vardakou et al. 
2011) 
Ex vivo methods 
Caco-2 cell culture Luminal and 
intracellular intestinal 
digestion, transport  
Hours + cell culture 
preparation; requires animal 
cell culture facilities 
(Dhuique-Mayer 
et al. 2007) 
Isolated organs Luminal, mucosal and 
intracellular digestion of 
a given organ, transport
Hours (Curtis et al. 1978) 
Bacterial culture Microbial digestion in 
large intestine; ability to 
provide essential amino 
acids 
Hours; requires 
microbiological facilities 
(Bender 1958) 
In vivo methods 
Nitrogen balance Whole digestion process 
in a given health 
condition 
Days-weeks; may require 
isotope labeling 
(Mokady et al. 
1969) 
Cannula/probe Digestive process up to 
the point of probing 
without data on 
digestion products  
Days(cannula); hours(probe); 
applicable for human 
(Darragh & 
Hodgkinson 2000; 
Faber et al. 2010) 
In silico methods 
QSAR Predicts degradation in 
any conditions 
depending on model 
Minutes (computation), weeks 
to months (database and 
model development); requires 
large experimental body (data 
on 100-200 proteins) 
(Foltz et al. 2009) 
Table 2. A comparison of different method classes for protein digestibility evaluation 
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one picture (cf., for example, the discussion in the work by Sterchi et al. (Sterchi & Woodley 
1980a)). 
The aim of a substantial part of pharmacological studies of peptide- and protein-based 
therapeutics is often the evaluation of the disintegration, dissolution and drug release 
profiles of oral drug formulations (Vardakou et al. 2011). Thus another aspect of food 
digestion becomes important – the mechanical grinding and mixing forces, exerted on a 
pharmaceutical formulation by various digestive tract compartments. To simulate such 
conditions devices of various complexity are employed (Schasteen et al. 2002; Vardakou et 
al. 2011). The applicability of such devices for the drug form disintegration testing is 
unquestionable, however, usually they reproduce only the luminal phase of food digestion. 
Thus the evaluation of the ability of released protein or peptide to get to the blood flow 
intact requires additional methods. 
A short reference of available method types is provided in table 2. It should be noted, that 
some in vitro methods could be combined and expanded to provide more relevant data. For 
example, single-enzyme digestions by stomach and small intestine could be performed 
sequentially, the Caco-2 cell culture is often overlaid by a simulated gastric fluid and 
possibly mucin (to protect cells and imitate the similar layer present in vivo). The 
computational methods are the most adaptive and powerful ones, however, to date their 
usability is limited to large screening studies due to huge preparatory experimental work. 
5. Conclusion 
Significant progress has been made in the modeling of protein digestion and absorption in 
gastrointestinal tract since the first works on this topic in the beginning of the XX century. A 
multitude of methods of various complexity, biological significance, animal requirements 
and human applicability now exist to answer the question on digestibility of proteins and 
peptides. The degree of biological processes imitation ranges from single luminal enzymes 
in simulated gastric or intestinal fluid model to sophisticated devices, which take in account 
grinding, mixing and turbulence forces and transition times, as well as isolated animal 
organs. 
There is, however, no single method, which will suit every possible research goal. The 
problem is, that as the biological significance increases, time and labor requirements also 
rise tremendously, and methods became progressively less suitable for high throughput 
screening, which is often required. In addition to this, there is no experimental model, which 
could imitate every last component of the digestion process. The enzyme-only models and 
organ fragments ignore mechanical forces, digestive devices lack intracellular hydrolases 
and transport steps, isolated organs usually represent only one compartment of the whole 
system, and they fail to exert mechanical forces as well. As there is no efficient methodology 
of sampling of the digested products after they are absorbed, but before they enter blood or 
lymph, whole animal models are also limited – they can only answer questions, whether a 
protein was absorbed and if it was suitable for the sustaining normal growth of an 
organism. A very promising approach has appeared with the development of the high-
performance computation methods, that is, molecular modeling. Theoretically, 
mathematical modeling is able to join data on the digestion patterns of various proteins 
from in vitro experiments with the results of in vivo tests of the ability of an organism to 
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utilize these proteins. However, a vast array of preliminary data is required for optimization 
and validation of such models, and so they are relatively rare. 
Thus, when considering various methods of protein digestibility assay, one should first of 
all define the limitations of the research at hand. If a high throughput screening is required? 
If there is a need for any data on digestion products? If absorption efficiency could vary and 
is essential? If a protein should serve as food or not? A possible decision tree for method 
optimization is presented on figure 1, albeit it should be considered more as a reference than 
a rule. 
 
Fig. 1. A decision tree for protein or peptide digestibility assay choice 
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